Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.
ScienceAlert on MSN
Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already
Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...
Could it be possible to diagnose Parkinson's disease with the help of a simple retinal exam? The idea should be seriously considered, according to a study published in the May issue of Neurobiology of ...
The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...
Doctors noticed an instant improvement in Parkinson’s disease patient Denise Bacon’s mobility during the procedure, known as ...
Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...
News-Medical.Net on MSN
World's largest-ever clinical trial launched to test treatments for Parkinson's disease
The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...
Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Cognitive decline and anxiety in Parkinson's disease are often only recognized at a late stage, yet they can greatly impact people's lives. Research by Marit Ruitenberg focuses on new tests and ...
A new study led by Rice University's Pernilla Wittung-Stafshede has revealed that protein clumps, or plaques that clog the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results